123 related articles for article (PubMed ID: 37604220)
1. Gypenosides suppress hepatocellular carcinoma cells by blocking cholesterol biosynthesis through inhibition of MVA pathway enzyme HMGCS1.
Xiao MY; Li FF; Xie P; Qi YS; Xie JB; Pei WJ; Luo HT; Guo M; Gu YL; Piao XL
Chem Biol Interact; 2023 Sep; 383():110674. PubMed ID: 37604220
[TBL] [Abstract][Full Text] [Related]
2. Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response.
Xiao MY; Pei WJ; Li S; Li FF; Xie P; Luo HT; Hyun Yoo H; Piao XL
Bioorg Chem; 2024 Jun; 150():107539. PubMed ID: 38861912
[TBL] [Abstract][Full Text] [Related]
3. CSN6-SPOP-HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation.
Li K; Zhang J; Lyu H; Yang J; Wei W; Wang Y; Luo H; Zhang Y; Jiang X; Yi H; Wang M; Zhang C; Wu K; Xiao L; Wen W; Xu H; Li G; Wan Y; Yang F; Yang R; Fu X; Qin B; Zhou Z; Zhang H; Lee MH
Adv Sci (Weinh); 2024 Apr; 11(14):e2306827. PubMed ID: 38308184
[TBL] [Abstract][Full Text] [Related]
4. Gypenoside L, Isolated from Gynostemma pentaphyllum, Induces Cytoplasmic Vacuolation Death in Hepatocellular Carcinoma Cells through Reactive-Oxygen-Species-Mediated Unfolded Protein Response.
Zheng K; Liao C; Li Y; Fan X; Fan L; Xu H; Kang Q; Zeng Y; Wu X; Wu H; Liu L; Xiao X; Zhang J; Wang Y; He Z
J Agric Food Chem; 2016 Mar; 64(8):1702-11. PubMed ID: 26870999
[TBL] [Abstract][Full Text] [Related]
5. Effects of heat-processed Gynostemma pentaphyllum on high-fat diet-fed mice of obesity and functional analysis on network pharmacology and molecular docking strategy.
Xie P; Guo M; Xie JB; Xiao MY; Qi YS; Duan Y; Li FF; Piao XL
J Ethnopharmacol; 2022 Aug; 294():115335. PubMed ID: 35513215
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic drug metformin suppresses tumorigenesis through inhibition of mevalonate pathway enzyme HMGCS1.
Chen Y; Li M; Yang Y; Lu Y; Li X
J Biol Chem; 2022 Dec; 298(12):102678. PubMed ID: 36356901
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting cholesterol de novo synthesis promotes hepatocellular carcinoma progression by upregulating prostaglandin E synthase 2-mediated arachidonic acid metabolism under high fatty acid conditions.
Zhao Z; Liu X; Xiang Y; Hou Z; He K; Zhong G; Hu J; Cai D; Liu Y; Ren J; Gong J; Zhao L
Cancer Sci; 2024 Feb; 115(2):477-489. PubMed ID: 38081591
[TBL] [Abstract][Full Text] [Related]
8. Gypenosides mediate cholesterol efflux and suppress oxidized LDL induced inflammation in retinal pigment epithelium cells.
Biswas L; Zeng Z; Graham A; Shu X
Exp Eye Res; 2020 Feb; 191():107931. PubMed ID: 31931003
[TBL] [Abstract][Full Text] [Related]
9. Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK Pathway.
Zhou S; Xu H; Tang Q; Xia H; Bi F
Mol Cancer Ther; 2020 Jan; 19(1):135-146. PubMed ID: 31554653
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death.
Pandyra AA; Mullen PJ; Goard CA; Ericson E; Sharma P; Kalkat M; Yu R; Pong JT; Brown KR; Hart T; Gebbia M; Lang KS; Giaever G; Nislow C; Moffat J; Penn LZ
Oncotarget; 2015 Sep; 6(29):26909-21. PubMed ID: 26353928
[TBL] [Abstract][Full Text] [Related]
11. Caspase-3-Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma.
Mok EHK; Leung CON; Zhou L; Lei MML; Leung HW; Tong M; Wong TL; Lau EYT; Ng IOL; Ding J; Yun JP; Yu J; Zhu HL; Lin CH; Lindholm D; Leung KS; Cybulski JD; Baker DM; Ma S; Lee TKW
Cancer Res; 2022 Sep; 82(17):3102-3115. PubMed ID: 35767704
[TBL] [Abstract][Full Text] [Related]
12. Krüppel-like Factor 13 Promotes HCC Progression by Transcriptional Regulation of HMGCS1-mediated Cholesterol Synthesis.
Chen CC; Xie XM; Zhao XK; Zuo S; Li HY
J Clin Transl Hepatol; 2022 Dec; 10(6):1125-1137. PubMed ID: 36381108
[TBL] [Abstract][Full Text] [Related]
13. The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer.
Walsh CA; Akrap N; Garre E; Magnusson Y; Harrison H; Andersson D; Jonasson E; Rafnsdottir S; Choudhry H; Buffa F; Ragoussis J; Ståhlberg A; Harris A; Landberg G
PLoS One; 2020; 15(7):e0236187. PubMed ID: 32692762
[TBL] [Abstract][Full Text] [Related]
14. Gypenoside L and Gypenoside LI Inhibit Proliferation in Renal Cell Carcinoma
Liu H; Li X; Xie J; Lv C; Lian F; Zhang S; Duan Y; Zeng Y; Piao X
Front Pharmacol; 2022; 13():820639. PubMed ID: 35370678
[TBL] [Abstract][Full Text] [Related]
15. Gypenosides induce apoptosis by ca2+ overload mediated by endoplasmic-reticulum and store-operated ca2+ channels in human hepatoma cells.
Sun DP; Li XX; Liu XL; Zhao D; Qiu FQ; Li Y; Ma P
Cancer Biother Radiopharm; 2013 May; 28(4):320-6. PubMed ID: 25310348
[TBL] [Abstract][Full Text] [Related]
16. Gypenosides induced G0/G1 arrest via inhibition of cyclin E and induction of apoptosis via activation of caspases-3 and -9 in human lung cancer A-549 cells.
Lu HF; Chen YS; Yang JS; Chen JC; Lu KW; Chiu TH; Liu KC; Yeh CC; Chen GW; Lin HJ; Chung JG
In Vivo; 2008; 22(2):215-21. PubMed ID: 18468406
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive serum metabolomics and network analysis to reveal the mechanism of gypenosides in treating lung cancer and enhancing the pharmacological effects of cisplatin.
Qi YS; Xiao MY; Xie P; Xie JB; Guo M; Li FF; Piao XL
Front Pharmacol; 2022; 13():1070948. PubMed ID: 36532716
[TBL] [Abstract][Full Text] [Related]
18. Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation.
Kong L; Wang X; Zhang K; Yuan W; Yang Q; Fan J; Wang P; Liu Q
PLoS One; 2015; 10(9):e0137888. PubMed ID: 26368019
[TBL] [Abstract][Full Text] [Related]
19. Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways.
Lu KW; Chen JC; Lai TY; Yang JS; Weng SW; Ma YS; Lu PJ; Weng JR; Chueh FS; Wood WG; Chung JG
Hum Exp Toxicol; 2011 May; 30(5):406-15. PubMed ID: 20511288
[TBL] [Abstract][Full Text] [Related]
20. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway.
Shen S; Wang K; Zhi Y; Shen W; Huang L
Cell Cycle; 2020 Nov; 19(22):3042-3053. PubMed ID: 33121337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
